Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ECPL is a real monster!
IKAN bouncing
buys coming in
needs to break 3 imo then it goes
lots of sellers still here
IKAN could be bouncing here
1.07 is the low.
MFLU 2nd qtr. out
3c increase in earnings. Rev. up 30%. The herd hasn't arrived yet!
http://ih.advfn.com/p.php?pid=nmona&article=43949526&symbol=NB%5EMFLU
Hmmm Is the market asleep on this?
MFLU 2nd qtr earnings out
looks like a swing of 3c from -2c to +1 for the qtr.
http://ih.advfn.com/p.php?pid=nmona&article=43949526&symbol=NB%5EMFLU
ILNS up to 29 now
GGII chasing its tail again
GGII green!
maybe they're thru dumping. Have to wait for the EOD to confirm.
ILNS
some nice news out! I'm in at .025
Press Release Source: Intellect Neurosciences, Inc. On Monday August 9, 2010, 8:00 am EDT
NEW YORK, Aug. 9, 2010 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc (OTCBB:ILNS - News) announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON(TM)), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease. The Company has successfully tested OX1 in human Phase I safety trials, providing initial positive data on safety and tolerability of the drug.
The Notice of Allowance is a written communication from the patent office stating that the application has been allowed and will be granted as a Canadian patent. Patents for OX1 have been issued in the United States, Europe and other countries and are pending in Japan and Mexico. The patents are jointly owned by New York University and the University of South Alabama and are licensed exclusively to Intellect Neurosciences.
Dr. Daniel Chain, Intellect's Chairman and CEO, commented: "OX1 is the most advanced candidate in our internal pipeline and has the potential to slow down or arrest Alzheimer's disease in the early stages by stabilizing amyloid beta in non-toxic form and preventing oxidative damage leading to inflammation and cell death. Moreover, based on OX1's mechanism of action, we believe it has applications for other disease indications as well. The Notice of Allowance of a new patent in Canada relating to OX1 strengthens our intellectual property portfolio and the competitive advantage of our internal drug development pipeline, which boasts clinical stage and preclinical programs. Our goal is to develop OX1 through strategic relationships with major pharmaceutical companies from whom we could obtain R&D funding and revenues from license fees, milestone payments, and royalties. We intend to build off of our previous successes in granting royalty-bearing licenses to major pharmaceutical companies that are developing drugs in Phase 2 and Phase 3 clinical trials for Alzheimer's disease."
About OXIGON(TM) (OX1)
The development of the OXIGON(TM) compound has been supported in part by the National Institute of Aging, the BIRD Foundation and The Institute for the Study of Aging. Intellect is developing OXIGON(TM) as a drug candidate for Alzheimer's disease and is exploring additional indications. The drug has disease-modifying potential because it has potent antioxidant activity and also can prevent aggregation, neurotoxicity and deposition of amyloid beta. The molecule was recently shown to act by a copper-binding mechanism, providing important insight into how the drug neutralizes neurotoxicity in the brain. OXIGON(TM) has been tested in human Phase 1 trials for safety and tolerability at various doses and durations in a total of 90 elderly, healthy volunteers. The next planned stage of testing will be in patients with Alzheimer's disease. OX1 has broad potential for use in the treatment of other neurodegenerative conditions, such as Parkinson's disease and motor neuron disease.
About Alzheimer's Disease
Alzheimer's disease, the most common form of dementia, is characterized by progressive loss of memory and cognition, ultimately leading to complete debilitation and death. A hallmark feature of Alzheimer's pathology is the presence of insoluble protein deposits, known as amyloid beta, on the surface of nerve cells, which results from the accumulation of soluble neurotoxic amyloid beta in the brain. The effects of the disease are devastating to patients as well as their caregivers, with significant associated health care costs. It is estimated that there are more than five million Americans and about 30 million people worldwide suffering from Alzheimer's disease, with the number expected to increase dramatically as the global population ages. Currently-marketed drugs transiently affect some symptoms of the disease, but there are no drugs on the market today that slow or arrest the progression of the disease. These symptomatic drugs are projected to generate more than US $6 billion in sales this year, indicating both the size of the market and the demand for effective treatment beyond symptomatic improvements.
About Intellect Neurosciences, Inc.
Intellect Neurosciences, Inc. is a Manhattan-based biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and other disorders. The Company's drug product pipeline includes OX1, which has been tested in Phase 1 clinical trials; IN-N01, a humanized monoclonal antibody designed to promote the clearance of soluble amyloid beta; and RECALL-VAX, a vaccine technology that has the potential to delay or prevent Alzheimer's disease in people who are at risk.
The Company has significant intellectual property assets, which include several patent families underlying the Company's internal programs, and a pivotal patent estate regarding passive AD immunotherapy.
IKAN
looking for a bounce tomorrow
IKAN
took a big hit today. In at 1.18. Just playing the bounce here.
ECPL looking better today
only 2mm left at 5 :)
some nice big blocks at 4 going thru :)
GGII news out
Green Globe International, Inc. Announces Intention to Expand International Territories Licensed to Certification Partner
Date : 08/04/2010 @ 9:58AM
Source : GlobeNewswire Inc.
Stock : Green Globe International, Inc. (GGII)
Quote : 0.0045 0.0004 (9.76%) @ 10:01AM
Green Globe International, Inc. Announces Intention to Expand International Territories Licensed to Certification Partner
Green Globe International (OTC) (USOTC:GGII)
Intraday Stock Chart
Today : Wednesday 4 August 2010
Green Globe International, Inc. (Pink Sheets:GGII), the worldwide owner of the Green Globe brand, today announced its intention to expand the non-exclusive license for its certification partner, Green Globe Certification, which is represented in over 83 countries, to include additional territories around the world.
"Since we first granted Green Globe Certification its license to represent the brand through its certification program in specified territories around the world, it has made significant progress in advancing the brand in those regions," said Steven R. Peacock, Managing Director and Chief Executive Officer of Green Globe International. "For a variety of reasons, we now believe it is the time to modify Green Globe Certification's non-exclusive license to include additional areas. We expect to have the modified agreement in place very shortly and will announce the specifics at that time.
"Green Globe International's core focus is to expand the use of the Green Globe brand in revenue generating sustainability applications around the world, and this planned modification is consistent with that focus. All of our licensees must maintain their adherence to the Green Globe Standards, which are among the most respected sustainability standards in use today. Licensees must also meet certain performance standards with respect to the advancement of the brand, and we believe that this is another area in which Green Globe Certification has made progress since entering into its licensing agreement.
"This modification is a tribute to the hard work of the Green Globe Certification team, and we look forward to the additional expansion of this certification program in markets worldwide," Mr. Peacock added.
Green Globe International has recently commented on several new milestones reached by Green Globe Certification, including the first hotel in the country of Oman to be certified. For additional information on Green Globe and its programs, please visit www.greenglobeint.com.
The Green Globe brand and program, which traces its roots back to the United Nations Rio de Janeiro Earth Summit in 1992, where 182 Heads of State endorsed the Agenda 21 principles of Sustainable Development, has primarily been used in the travel and tourism industry but is now being expanded to include a growing number of environmentally responsible businesses in a variety of market sectors. The Green Globe brand is an ideal symbol for the world's increasing awareness of environmental responsibility and response to global climate change.
The company encourages all shareholders and others interested in following the progress of the Green Globe brand to subscribe to receive email alerts whenever new information is made public. To subscribe, please visit http://www.greenglobeint.com/stayconnected/email/.
About Green Globe International, Inc.
Green Globe International, Inc. is the worldwide owner of the Green Globe brand, which includes the leading sustainability certification and benchmarking programs, carbon footprint calculation and offset programs, and a broad range of consulting services. Green Globe International has been admitted as an affiliate member of the United Nations World Tourism Organization. The World Travel & Tourism Council (WTTC), the business leaders' forum for the travel and tourism industry, is a 5% common stock owner of Green Globe International. For more information on the company and its programs, please visit www.greenglobeint.com.
The Green Globe International, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6582
For information on Green Globe Certification, please visit www.greenglobe.com. To see sustainable travel options, please visit www.greenglobe.travel.
Green Globe services in the Asia Pacific are distributed, managed and sold exclusively by Green Globe Asia Pacific (GGAP) through EC3 Global. If you would like further information on GGAP, please visit www.greenglobe.org.
Safe Harbor Statement
This release contains forward-looking statements with respect to the results of operations and business of Green Globe International, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
CONTACT: Green Globe International, Inc.
Public Relations and Communications
888-528-0883
corporate@greenglobeint.com
ECPL
nite just went to 5 :)
ECPL
only one monkey left at 4 :)
ECPL
could bounce hard today imo
ECPL
got some cheapies this am :)
morning everyone!
4 X .0004 3 X .0005
GGII
added at the 5s here on some nice news!
http://ih.advfn.com/p.php?pid=nmona&article=43853067&symbol=NO%5EGGII
1 X5 2 X6
TGGI
finished at 5 hod. looking sweet!
TGGI
only 1 left at 5s :)
TGGI
supposed to reduce share count by 500m?
snagged some 4s today. we'll see.
out at 9s yesterday
may reload at 6s :)
VIVK
moving up. looking at 19s now
IKTO hittin 9s :)
no
lot of 50k trades
so could be dilution but bid support at 7 seems to be strong. Have to wait and see
GGII bid ut
cheapies wont last long imo.
GGII
buying the dip here
morning everyone!
this one looks nice:
http://stockcharts.com/h-sc/ui?s=CXM
I'm out with a quick profit :)
ILNS
bouncy bouncy :)
morning MOOvers!
BYSD
grabbed some 11's 4 X 1 now
VIVK up 51%
1 X .0195 1X .02